Immunocidin Equine

Immunocidin Equine is a CFIA-approved immunotherapeutic indicated for the treatment of sarcoid tumors in horses. This intratumoural suspension features an emulsion of modified mycobacterial cell wall fractions designed to reduce toxic and allergic effects while retaining antitumour activity. It stimulates macrophages and thymic lymphocytes to target and kill tumor cells and has a high post-treatment tumor-free rate. Well tolerated by horses, including older animals, it has minimal side effects and is safe for use in pregnant mares—an advanced choice for equine health and livestock health products.